Anti-Angiogenic Therapy in Ophthalmology

<div>CONTENTS</div><div>1 Retinal Vascular Development</div><div>Jing Chen, Chi-Hsiu Liu, and Przemyslaw Sapieha</div><div>2 Retinopathy of Prematurity</div><div>Andreas Stahl, Ann Hellstrom, and Lois E. H. Smith</div><div>3 Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors</div><div>Dujon Fuzzard, Robyn H. Guymer, and Robert P. Finger</div><div>4 AREDS Supplementation and the Progression Towards Neovascular Exudative AMD</div><div>David Valent and Emily Y. Chew</div><div></div>5 VEGF-Inhibition in Macular Telangiectasia Type 2<div>Peter Charbel Issa and Frank G. Holz</div><div>6 Diabetic Retinopathy</div><div>Focke Ziemssen and Hansjürgen T. Agostini</div><div>7 Retinal Vein Occlusion</div><div>Amelie Pielen, Bernd Junker, and Nicolas Feltgen</div><div>8 Pharmacokinetics of Intravitreally Applied VEGF Inhibitors</div><div>Tim U. Krohne, Frank G. Holz, and Carsten H. Meyer</div><div>9 Neovascular Glaucoma</div><div>Julia Lüke, Matthias Lüke, and Salvatore Grisanti</div><div></div>10 Corneal Neovascular Diseases<div>Deniz Hos, Felix Bock, Björn Bachmann, and Claus Cursiefen</div><div>11 Anti‐Angiogenic Gene Therapy - Basic Science and Challenges for Translation into the Clinic</div><div>Clemens Lange and James Bainbridge</div><div><br></div>